Clinical Trial Update: Safety Study of TRK-820 for Patient With Hemodialysis [Phase 1]

View source ↗

Summary

Phase 1 safety study of TRK-820 in patients undergoing hemodialysis for chronic kidney disease has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease
• End-stage Renal Disease

Drugs mentioned

• TRK-820

Snippet

Sponsor: SK Chemicals Co., Ltd. | Conditions: Chronic Renal Failure | Phase 1 | Status: COMPLETED